HF
RNXT icon

HRT Financial’s RenovoRx RNXT Stock Holding History

HRT Financial’s Portfolio RNXT Stock Details RNXT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-43,120
Closed -$43K – 5181
2026
Q1 		$43K Buy
43,120
+32,394
+302% +$31.4K ﹤0.01% 3470
2025
Q4 		$9K Sell
10,726
-14,044
-57% -$14.1K ﹤0.01% 3048
2025
Q3 		$31K Buy
24,770
+4,138
+20% +$4.92K ﹤0.01% 2656
2025
Q2 		$27K Buy
+20,632
New +$23.5K ﹤0.01% 2369
2024
Q3 		– Sell
-11,743
Closed -$13K – 3030
2024
Q2 		$13K Buy
+11,743
New +$14.4K ﹤0.01% 1976
2024
Q1 		– Sell
-14,041
Closed -$32K – 2975
2023
Q4 		$32K Buy
+14,041
New +$13.4K ﹤0.01% 1999

Other funds holding RNXT

ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WANY
Wealthspire Advisors (New York) New York $18.2B AUM 21.48% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
CPIG
Chicago Partners Investment Group Chicago, Illinois $5B AUM 26.84% 1-Year Est. Return
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management Milwaukee, Wisconsin $187B AUM 21.7% 1-Year Est. Return

HRT Financial's RNXT Position: Q2 2026 in Review

HRT Financial sold out of RenovoRx (RNXT) in Q2 2026, closing a stake of 43,120 shares — an estimated $43K sold.

HRT Financial first reported a position in RNXT in Q4 2023 and held it in 6 quarters. The position peaked at $43K in Q1 2026. 28 funds tracked by Wall St. Rank hold RNXT as of Q2 2026.

  • HRT Financial reported no remaining RenovoRx position as of Q2 2026 after selling out during the quarter.
  • HRT Financial sold 43,120 RenovoRx shares in Q2 2026, an estimated $43K.
  • HRT Financial first reported a position in RenovoRx in Q4 2023 and held it in 6 quarters.
  • HRT Financial's RenovoRx position peaked at $43K in Q1 2026.
  • 28 funds tracked by Wall St. Rank held RenovoRx as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.